Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma
SNS-032（一种强效且选择性的 Cdk2、7 和 9 抑制剂）在晚期慢性淋巴细胞白血病和多发性骨髓瘤患者中的 I 期药理学研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2009.26.1347
Tong, Wei-Gang; Chen, Rong; Plunkett, William; Siegel, David; Sinha, Rajni; Harvey, R Donald; Badros, Ashraf Z; Popplewell, Leslie; Coutre, Steven; Fox, Judith A; Mahadocon, Kristi; Chen, Tianling; Kegley, Peggy; Hoch, Ute; Wierda, William G
